Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02266745
Title A Phase 1 Study of PT-112 Injection in Subjects With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Phosplatin Therapeutics
Indications
Therapies
Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Arizona Phoenix Arizona 85054 United States Details
Tucson Tucson Arizona 85719 United States Details
Duarte Duarte California 91010 United States Details
Colorado Aurora Colorado 80045 United States Details
Jacksonville Jacksonville Florida 32224 United States Details
Orlando Orlando Florida 32806 United States Details
Indianapolis Indianapolis Indiana 46202 United States Details
Boston Boston Massachusetts 02215 United States Details
Minneapolis Minneapolis Minnesota 55426 United States Details
Rochester Rochester Minnesota 55905 United States Details
Omaha Omaha Nebraska 68130 United States Details
Albuquerque Albuquerque New Mexico 87190 United States Details
Brooklyn Brooklyn New York 11215 United States Details
New York New York New York 10065 United States Details
Durham Durham North Carolina 27705 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Seattle Seattle Washington 19024 United States Details
Besançon Besançon France Details
Bordeaux Bordeaux France Details
Caen Caen France Details
Clermont-Ferrand Clermont-Ferrand France Details
Marseille Marseille France Details
Nice Nice France Details
Paris Paris France Details
Rennes Rennes France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field